Imiquimod: all 126 studies that test it
Page 2 of 2. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in InfancyCompletedNCT00601016Phase 2
- Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL PatientsTerminatedNCT00596336Phase 2
- Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)CompletedNCT00581425Phase 4
- A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the BaseStatus unknownNCT00463359Not applicable
- Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the SkinCompletedNCT00453050Phase 1
- Topical Imiquimod for Bowen's Disease of the Head and NeckStatus unknownNCT00384124Phase 2/3
- Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% CreamCompletedNCT00335179Phase 2
- Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After CurettageCompletedNCT00314756Phase 4
- Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis LesionsCompletedNCT00294320Phase 3
- Imiquimod Plus Antimony Immunochemotherapy for Cutaneous LeishmaniasisCompletedNCT00257530Phase 3
- Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label StudyWithdrawnNCT00230373Phase 3
- Safety and Efficacy Study of Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell CarcinomaCompletedNCT00204555Phase 4
- Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital WartsCompletedNCT00189293Phase 4
- Aldara for the Treatment of Large and/or Multiple sBCCCompletedNCT00189280Phase 3
- A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant RecipientsCompletedNCT00189267Phase 2
- A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell CarcinomaCompletedNCT00189241Phase 3
- Aldara for the Treatment of Extensive Alopecia AreataCompletedNCT00177021Phase 4
- Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5%CompletedNCT00176943Phase 4
- Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic KeratosesCompletedNCT00175643Phase 3
- Imiquimod in Children With Plaque MorpheaCompletedNCT00147771Phase 3
- A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma RecurrenceCompletedNCT00129519Phase 3
- Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV MelanomaCompletedNCT00118313Phase 1
- Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and HandsCompletedNCT00115154Phase 4
- Imiquimod Cream in Treating Patients With Basal Cell Skin CancerCompletedNCT00079300Phase 1
- Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin CancerCompletedNCT00066872Phase 3
- Imiquimod in Preventing Cervical Cancer in Women With Cervical NeoplasiaCompletedNCT00031759Phase 2